logo
MRI May Aid Early Pancreatic Cancer Detection in Diabetes

MRI May Aid Early Pancreatic Cancer Detection in Diabetes

Medscape5 hours ago
TOPLINE:
MRI-based screening in patients older than 50 years with new-onset or deteriorating diabetes detected stage IB pancreatic cancer in a patient with deteriorating diabetes, highlighting the need for targeted screening in this high-risk population.
METHODOLOGY:
New-onset diabetes in patients older than 50 years was found to increase the risk for pancreatic cancer by six- to eight-fold, and recent evidence suggests that the deterioration of diabetes in individuals with stable, long-standing disease may also be an indicator of subclinical pancreatic cancer.
Researchers conducted the PANDOME study to evaluate the effectiveness and safety of MRI-based screening for the early detection of pancreatic cancer in patients with new-onset diabetes (n = 97; median age, 61 years; 63.9% women) or deteriorating diabetes (n = 12; median age, 68 years; 58.3% women).
New-onset diabetes was defined as elevated A1c levels within the past 12 months, whereas deteriorating diabetes was defined as long-standing diabetes (> 2 years) with a > 2% increase in A1c levels over the past 6 months not linked to weight gain or diabetes medication noncompliance.
All patients underwent MRI/cholangiopancreatography, blood biobanking, and anxiety/depression monitoring; MRI results were scored as normal, benign-abnormal, suspicious, or incidental findings.
TAKEAWAY:
Compared with patients with new-onset diabetes, those with deteriorating diabetes had significantly higher A1c levels (P = .02), greater weight loss (P = .0038), and increased insulin requirements (P < .0001).
Among 109 participants, more than 50% had small cystic lesions with an average size of 6 mm, prompting seven endoscopic ultrasound procedures — four of which required biopsies. Of the four pancreatic biopsies performed, one revealed stage IB pancreatic ductal adenocarcinoma in a patient with deteriorating diabetes.
Extra-pancreatic incidental findings were detected in 8.2% of cases, with two requiring biopsies, revealing one new diagnosis of follicular lymphoma and one diagnosis of recurrent lymphoma.
According to the Enriching New-Onset Diabetes for Pancreatic Cancer score — where a high-risk score predicts a 3.6% probability of pancreatic cancer within 3 years — the deteriorating diabetes group had a higher proportion of high-risk individuals than the new-onset diabetes group (75% vs 35.6%).
IN PRACTICE:
'Preliminary results from the PANDOME study support further MRI-based PC [pancreatic cancer] screening research efforts in individuals with NOD [new-onset diabetes] and DD [deteriorating diabetes],' the authors concluded.
SOURCE:
This study was led by Richard Frank, MD, Division of Hematology/Oncology, Nuvance Health, Norwalk, Connecticut. It was published online in The Journal of Clinical Endocrinology & Metabolism.
LIMITATIONS:
T his study faced challenges with low accrual rates due to healthcare network realignments and high declination rates by potential participants. Selection bias potentially led to lower detection rates, as most participants were referred by primary care physicians or endocrinologists. Moreover, the majority of participants were White individuals (83%), despite higher pancreatic cancer risk among Black populations, limiting generalizability.
DISCLOSURES:
This study received support from a Tribute to Pamela/The Naughton Family Fund, the Rallye for Pancreatic Cancer, Pacific Crest Trail for Pancreatic Cancer, and the Glenn W. Bailey Foundation. The authors declared no conflicts of interest.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sunvozertinib Wins Approval for EGFR-Mutated NSCLC
Sunvozertinib Wins Approval for EGFR-Mutated NSCLC

Medscape

time17 minutes ago

  • Medscape

Sunvozertinib Wins Approval for EGFR-Mutated NSCLC

The FDA has granted accelerated approval to sunvozertinib (Zegfrovy, Dizal Pharmaceutical) for locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor ( EGFR) exon 20 insertion mutations that's progressed on or after platinum-based chemotherapy. The agency also approved Oncomine Dx Express Test (Life Technologies Corporation) as a companion diagnostic to detect the mutations. The oral EGFR inhibitor is the first small molecule approved in the US for the indication; it was previously approved in China. The intravenous bispecific antibody amivantamab-vmjw (Rybrevant, Johnson & Johnson) also carries a second-line indication for EGFR exon 20 insertion mutated advanced/metastatic NSCLC, as well as a first-line indication with carboplatin and pemetrexed. Dizal is going for a first-line indication, too. The company recently announced completion of enrolment in a phase 3 trial pitting sunvozertinib against platinum-based chemotherapy for the upfront treatment of EGFR exon 20 insertion mutated NSCLC. The new second-line approval was based on WU-KONG1B, a multinational dose finding trial. All subjects had previous platinum-based chemotherapy and 43.4% had also received immunotherapy; 13.3% had been on amivantamab. Among 85 patients on 200 mg sunvozertinib daily, the overall response rate was 46% and the duration of response was 11.1 months. Labelling warns of the possibility of interstitial lung disease/pneumonitis, gastrointestinal adverse reactions, dermatologic issues, ocular toxicity, and embryo-fetal toxicity. Diarrhea, skin rash, and creatine phosphokinase increase were the most common drug-related treatment emergent adverse events in the trial, with most events being grade 1 or 2. The recommended dose is 200 mg orally once daily with food until disease progression or unacceptable toxicity. M. Alexander Otto is a physician assistant with a master's degree in medical science and a journalism degree from Newhouse. He is an award-winning medical journalist who worked for several major news outlets before joining Medscape. Alex is also an MIT Knight Science Journalism fellow. Email: aotto@

NASA identifies newly discovered object as an interstellar comet that will keep a safe distance
NASA identifies newly discovered object as an interstellar comet that will keep a safe distance

Associated Press

time22 minutes ago

  • Associated Press

NASA identifies newly discovered object as an interstellar comet that will keep a safe distance

CAPE CANAVERAL, Fla. (AP) — NASA has discovered an interstellar comet that's wandered into our backyard. The space agency spotted the quick-moving object with the sky-surveying Atlas telescope in Chile earlier this week, and confirmed it was a comet from another star system. It's officially the third known interstellar object to pass through our solar system and poses no threat to Earth. The newest visitor is 416 million miles (670 million kilometers) from the sun, out near Jupiter. NASA said the comet will make its closest approach to the sun in October, scooting between the orbits of Mars and Earth — but closer to the red planet than us at a safe 150 million miles (240 million kilometers) away. Astronomers around the world are monitoring the comet — an icy snowball officially designated 3I/Atlas — to determine its size and shape. It should be visible by telescopes through September, before it gets too close to the sun, and reappear in December on the other side of the sun. The first interstellar visitor observed from Earth was Oumuamua, Hawaiian for scout, in honor of the observatory in Hawaii that discovered it in 2017. Classified at first as an asteroid, the elongated Oumuamua has since showed signs of being a comet. The second object confirmed to have strayed from another star system into our own —— 21/Borisov — was discovered in 2019 by a Crimean amateur astronomer with that name. It, too, is believed to be a comet. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

Lazerus: Fathers, sons and an unbreakable bond built on the absurdity of sports
Lazerus: Fathers, sons and an unbreakable bond built on the absurdity of sports

New York Times

time41 minutes ago

  • New York Times

Lazerus: Fathers, sons and an unbreakable bond built on the absurdity of sports

The first time my dad died, I spent three hours on a plane staring out the window, barely able to function, barely able to exist. Didn't fidget. Didn't read. Didn't do a crossword puzzle. I just stared at the clouds. I assume I blinked a few times, but I really can't say for sure. The plane's wifi was out, and the last I had heard, Dad's massive heart attack and subsequent quintuple-bypass surgery were essentially unsurvivable. I was supposed to be flying down to Florida that morning with my wife and daughters to spend spring break with my parents in a rented house on Siesta Key. Instead, I was flying solo to 'handle my father's affairs,' whatever that means. Advertisement As I stared into the void, all I could think about was ways to sum up the most important man in the universe, Steve Lazerus, the man who — for better or worse — made me the way I am. It's a curse of journalists, particularly sportswriters, that we think in ledes and narratives and kickers. We can't watch a baseball game from the couch without involuntarily conjuring a full story, can't sit through a movie without mentally drawing up a full review. And it turns out we — or, at least, I — can't process the death of a parent without turning it into a full-blown obituary. Hell, I'm doing it again right now, the second time my dad died. This time, it stuck. This time, there was no marvel of modern medicine, no team of doctors able to save him, no futuristic machine to keep his heart pumping and his kidneys functioning, no 26 days of sedation in the ICU, no long and grueling rehab, no harrowing flight back to New Jersey in a medical plane, no loss of 100 pounds, no extraordinary bounce-back, no three glorious years of life and love and grandparenting and 'Lindor!' texts and opportunities to bluntly say the things we had always felt but had never put into words. My dad cried when I told him how much I loved him, how important he was to me, how it felt to see him tied to all those tubes and machines. I cried when he told me how profound the depth of his love for my mom was, how he never truly understood until then her strength and the ferocity of her love. I wouldn't trade these last three years for anything in the world. They were the greatest gift our family will ever receive. But he's gone now. Suddenly and still too soon. I'm once again on a plane, to do … I don't know, whatever you do when your dad dies. To call credit-card companies and health-insurance companies and a hundred other companies and hear them tell you how sorry they are for your loss, and also could you please send them 14 forms of documentation by tomorrow? And to sit with my mom and cry and laugh and tell stories and wonder what we do now, who I'll call when I smell something weird in the basement or can't figure out why a light won't turn on or a million other things I've never needed to know because I could always just call my dad. Advertisement And I'm once again staggering blindly, trying to put such a monumental human into words. I want to be profound. I want to be poetic. But all I can think about are the stupid things. Stupid sports things, mostly. The way he would say, 'Hey, it's the Pro Football Hall of Fame' every single time we drove past one of those salt sheds that look like half a football. (I do this to my kids to this day.) The way he yelped, 'GET OUTTA HERE!' every time a Mets batter hit the ball in the air. (I do this one, too.) The way he said, 'Uh-oh!' every time the Islanders' opponent entered the zone. The way he would say, 'Sounds like a skin disease' every time Jiggs McDonald said the name 'Darius Kasparaitis.' The way he always said he was going to get a cardboard cutout of me to sit next to him on the couch when I left for college, because we watched just about every single Islanders game together for my entire childhood. And those were the brutally bad years. The Mike Milbury years. God, he hated Mike Milbury. God, it made me laugh. The way he cheered me on in Little League, and the way he called my mom — my devoted Little League coach for a decade — 'Charlie O'Brien' after the Mets catcher, for the way her 1980s perm poofed out the sides of her hat. My dad's the reason I spend most of my time at work making dumb puns on the internet instead of, you know, working. My dad's the reason I loved sports growing up, a 10-year-old unironically wearing a powder-blue T-shirt that said 'SPORTS NUT' on it, with a cartoon peanut holding a baseball bat and a tennis racket and kicking a football. My dad's the reason I memorized all of Mickey Mantle's World Series stats as, clearly, the world's coolest 8-year-old. My mom is everything to me, and molded me and shaped me and drove me and always believed in me even when I didn't believe in myself. But it was my dad who instilled in me my unhealthy love of sports, and, through his incessant dad jokes, the love of language that made a 12-year-old dream of one day becoming a real live sports columnist. And my dad got to see that happen. He got to see me realize my actual dream. How cool is that? He's certainly the only person on Earth who read just about every word I ever wrote, whether it was about the U.S. Open of polo, the Peters Township, Pa., high school hockey team, the Lake Central, Ind., high school baseball team, the Valparaiso University men's basketball team, the Chicago Blackhawks, and now the NHL and sporting world as a whole. Every 'great story today!' text I got from him meant the world. I'll forever be grateful for that. For him. That he won't read these words, or any of the ones that follow, cuts me to my core, to my very soul. Now? I don't know what to do now. I don't mean what to do at the funeral home or the bank or who to call and in what order to do things — though I sure don't know any of that. I mean, I don't know what to do. How to function. How to exist as a 45-year-old kid without a dad. Advertisement Oh, but he's still there. In my brilliant jokes that make everyone's eyes roll. In the way I shower my kids with love and affection and spectacular puns. I hear his voice and his humor and his personality just about every time I open my mouth, and, man, thank goodness for that. Those heavy conversations we had over the last three years were life-affirming and sustaining, but it's those dumb little jokes and throwaway comments that will linger in my mind. That was my dad at his daddest, working in inanity the way other artists worked in oil and clay, a true master. Hell, the last three texts I sent to my dad — the last three texts I'll ever send to my dad — are about as stupid as they get. One was a GIF of Pop Fisher, the fictional manager of the New York Knights in 'The Natural,' complaining about how much he hates losing to the Pirates. One was about how the Mets were 3-12 since they didn't let Grimace throw out the first pitch on his birthday as they did the year before. And one was mocking position player Travis Jankowski's 42-mph fastball in mop-up duty. They're not profound. They're not direct, heartfelt expressions of love and appreciation. They're not just an endless string of thank-yous for everything he did for me. Because, you know what? I got to spend the last three years doing that. Three years we almost didn't get. I'm so unbearably sad right now, my heart and my soul and my sense of self torn to shreds. But I'm also so unbelievably lucky I got those three years. Too many aren't so lucky. So yeah, my last three texts to my dad, the last things I ever said to him, were stupid. They were sophomoric. They were meaningless and histrionic and they were about the freaking New York Mets. They were perfect. (Photos courtesy of the Lazerus family)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store